arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

download Export Data

Century Therapeutics, Inc.

IPSC

$1.91 ▼ -0.06 (-3.30%) at close

26 Visible periods

30 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Weak

Bearish

auto_awesome

Analytical Summary

Century Therapeutics, Inc. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $369.5M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -7.1% ↗

FCF / Share $-0.13

Trailing P/E —

Price / Book 1.3x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

26-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

↓ -100.0% —

Net Income Profit after all expenses

$-21.64M

↓ -12.9% —

Operating Margin Operating profit as % of sales

-33.1%

↓ -4.2% 12th

FCF / Share Free cash flow per share

$-0.13

↑ +67.3% —

Long-Term Debt Long-term obligations

$10.39M

↑ +178.0% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↑

Returns ↑

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	N/M	13700.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+171159%)	14058.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+175634%)	12667.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+158246%)	1457.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+18114%)	434.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5331%)	678.8% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8385%)	-50.3% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-729%)	-48.6% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-707%)	-93.3% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1267%)	-92.9% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1261%)	62.6% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+682%)	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS Growth YoY (%)	N/M	41.9% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-8.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	33.8% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.7% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	32.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	15.1% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-18.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-3.8% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-3.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	19.7% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-129.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-10.4% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	72.0% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	72.4% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	88.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	72.6% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	5.9% Fair Fair Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	N/M	46.9% Excellent Excellent Year-over-year change in net income	N/M	N/M	N/M	8.4% Fair ↓ Fair Declining Year-over-year change in net income	10.2% Fair ↑ Fair Improving Year-over-year change in net income	10.2% Fair ↑ Fair Improving Year-over-year change in net income	10.2% Fair ↑ Fair Improving Year-over-year change in net income	-24.4% Weak ↓ Weak Declining Year-over-year change in net income	16.7% Good ↑ Good Improving Year-over-year change in net income	16.7% Good ↑ Good Improving Year-over-year change in net income	16.7% Good ↑ Good Improving Year-over-year change in net income	-12.4% Weak ↑ Weak Improving Year-over-year change in net income	-104.4% Weak ↓ Weak Declining Year-over-year change in net income	-104.4% Weak ↓ Weak Declining Year-over-year change in net income	-104.5% Weak ↓ Weak Declining Year-over-year change in net income	-81.5% Weak ↓ Weak Declining Year-over-year change in net income	-89.7% Weak Weak Year-over-year change in net income	-19.9% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	67.3% Excellent Excellent Year-over-year change in free cash flow	—	—	—	17.4% Good Good Year-over-year change in free cash flow	—	—	—	15.3% Good Good Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	N/M	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	266.1% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	327.6% Excellent Excellent Compound annual revenue growth over 3 years	369.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	-33.1% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-321%)	-31.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-312%)	67.9% Excellent Excellent Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+353%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	-5.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	2.2% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-1.8% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-2.9% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-4.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	70.1% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+484%)	70.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+484%)	70.1% Excellent Excellent Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+484%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF Margin (%) (%)	—	—	-23.6% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-25.6% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-32.2% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
FCF / Net Income (x)	1.19x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.34x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.36x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	-0.46x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.67x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	1.10x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	0.69x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.54x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.09x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	0.92x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	-2.20x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	1.46x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	1.31x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.97x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	1.42x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-7.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-10.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	24.4% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-24.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.8% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-15.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-23.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-16.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-11.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-4.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	15.6% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	12.5% Good Good Return earned on debt + equity capital invested Optimal: > 10%	8.0% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—	—	—
Return on Capital (%) (%)	-7.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	23.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-10.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-8.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-12.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-8.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-7.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.2% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-5.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-6.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-5.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-4.6% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-14.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-8.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-12.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-180%)	43.4% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+189%)	36.5% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+143%)	31.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+112%)	-22.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-249%)	-14.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-196%)	-12.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-15.8% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-21.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-242%)	-14.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-195%)	-12.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-184%)	-11.3% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-175%)	-10.5% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-11.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-176%)	-10.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-170%)	-9.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-7.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-147%)	-4.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-129%)	-4.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-127%)	20.0% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+34%)	14.6% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	7.5% Caution Caution Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-50%)	—	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	0.04x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-94%)	0.01x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-98%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-95%)	0.03x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	0.02x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-96%)	—	-0.09x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-115%)	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	-257.92x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-79.41x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	—	-85.09x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-95.00x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-119.22x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-87.14x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-80.21x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-72.39x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-57.52x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-47.39x Weak Weak Operating income divided by interest expense Optimal: > 5x	-222.56x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—
Net Debt (USD)	$-51.05M	$-61.85M	$-55.52M	$-56.88M	$-51.87M	$-58.44M	$-52.59M	$-41.46M	$-46.81M	$-47.32M	—	$-64.44M	$-76.44M	$-80.53M	$-100.95M	$-102.39M	$-115.64M	$-47.54M	$-90.90M	$-261.88M	—	$-17.57M	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	-0.36x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.36x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.35x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.29x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.33x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.42x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	-0.65x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	$1.26	$1.27	$1.27	—	$0.01	$0.01	$0.01	—	$0.00	$0.00	$0.03	—	$0.04	$0.02	$0.02	—	—	—	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.11	$-0.25	$-0.40	$-0.38	$0.89	$-0.43	$-0.37	$-0.38	$-0.45	$-0.65	$-0.55	$-0.56	$-0.53	$-0.55	$-0.53	$-0.54	$-0.66	$-0.24	$-0.48	$-1.93	$-2.39	$-2.08	$-1.75	$-2.05	—	—
Free Cash Flow per Share (USD)	$-0.13	—	$-0.30	$-0.32	$-0.41	—	—	—	$-0.49	—	$-0.28	—	$-0.58	—	—	—	$1.45	—	—	—	$-3.13	—	$-1.84	—	—	—
Book Value per Share (USD)	$1.47	$1.82	$2.04	$2.43	$2.79	$1.88	$2.31	$2.63	$2.95	$3.06	$3.69	$4.17	$4.69	$5.50	$5.68	$6.22	$6.71	$6.78	$7.74	$8.23	$-11.93	$-14.22	$-17.28	—	—	—
Tangible Book Value per Share (USD)	$1.28	$1.43	$1.64	$2.04	$2.39	$1.48	$1.86	$2.17	$2.95	$3.06	$3.69	$4.17	$4.69	$5.50	$5.68	$6.22	$6.71	$6.78	$7.74	$8.23	$-11.93	$-14.22	$-17.28	—	—	—
Basic Weighted Avg Shares (shares)	193.47M	—	86.46M	86.24M	86.02M	—	84.70M	82.09M	62.30M	—	59.45M	59.25M	58.61M	—	57.97M	57.69M	57.05M	—	54.47M	12.04M	7.68M	—	7.48M	7.48M	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$125.47M	$100.54M	$115.68M	$145.22M	$155.13M	$64.27M	$186.19M	$184.31M	$183.75M	$159.15M	—	$142.12M	$228.25M	$289.90M	$334.73M	$362.22M	$343.29M	$212.50M	$280.53M	$381.39M	—	$66.69M	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$10.39M	$3.74M	$10.39M	$10.39M	$10.39M	$8.90M	$10.39M	$10.39M	—	$9.64M	—	—	—	—
Total Equity (USD)	$264.74M	$158.94M	$176.35M	$209.90M	$240.44M	$161.36M	$195.69M	$222.10M	$177.88M	$184.75M	$219.23M	$247.57M	$277.18M	$302.74M	$330.20M	$357.95M	$386.66M	$396.24M	$422.99M	$447.60M	$-91.56M	$-106.41M	$-129.31M	—	$-101.28M	$-91.86M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	$0.00	$109.16M	$109.16M	$109.16M	$4.17M	$791.00K	$771.00K	$855.00K	$268.00K	$148.00K	$99.00K	$1.72M	$521.00K	$2.22M	$1.40M	$1.06M	—	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	$3.00M	$3.55M	$3.13M	$3.20M	$3.22M	$3.32M	$3.00K	$3.46M	$3.23M	$3.55M	$3.35M	$3.23M	$2.91M	$2.84M	$2.77M	$1.67M	$1.16M	$1.05M	$1.04M	$935.00K	$718.00K	$510.00K	$410.00K	$282.00K	—	—
Net Income, GAAP (USD)	$-21.64M	$-19.17M	$76.56M	$76.56M	$76.56M	$-36.07M	$-28.06M	$-28.06M	$-28.06M	$-39.40M	$-31.26M	$-31.26M	$-31.26M	$-31.68M	$-37.51M	$-37.51M	$-37.51M	$-28.19M	$-18.35M	$-18.35M	$-18.35M	$-15.53M	$-9.67M	$-15.30M	—	—
Operating Cash Flow (USD)	$-25.26M	$-16.08M	$-25.58M	$-27.59M	$-34.62M	$-24.22M	—	—	$-30.25M	$-26.23M	$-13.65M	—	$-29.22M	$-22.91M	—	—	$86.75M	$-24.35M	—	—	$-22.18M	$-13.22M	$-9.22M	—	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 26 quarters

Century Therapeutics, Inc.

Analytical Summary

26-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IPSC with peers